NEWAMSTERDAM PHARMA COMPANY

Ticker: NAMS CUSIP: N62509109 Class: Stock

Eversept Partners, LP's Holding History (CIK: 0001697013)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 420,827 Value ($000) $14,763 Avg Close $36.39 Range $28.19 - $42.00
Q3 2025
Shares 488,592 Value ($000) $13,896 Avg Close $23.97 Range $17.97 - $28.91
Q2 2025
Shares 414,430 Value ($000) $7,505 Avg Close $18.24 Range $14.06 - $22.25
Q1 2025
Shares 280,951 Value ($000) $5,751 Avg Close $22.23 Range $17.18 - $26.80
Q4 2024
Shares 275,362 Value ($000) $7,077 Avg Close $21.24 Range $15.51 - $27.29
Q3 2024
Shares 307,357 Value ($000) $5,102 Avg Close $17.30 Range $15.19 - $21.48
Q2 2024
Shares 329,890 Value ($000) $6,337 Avg Close $20.06 Range $16.62 - $24.79
Q1 2024
Shares 353,965 Value ($000) $8,371 Avg Close $20.30 Range $11.18 - $26.35
Q4 2023
Shares 374,404 Value ($000) $4,182 Avg Close $9.16 Range $5.63 - $11.89
Q3 2023
Shares 660,618 Value ($000) $6,111 Avg Close $10.83 Range $8.57 - $12.54
Q2 2023
Shares 692,369 Value ($000) $8,232 Avg Close $13.27 Range $11.03 - $17.00
Q1 2023
Shares 45,856 Value ($000) $608 Avg Close $12.62 Range $9.50 - $18.70